Immunisation in the current management of cystic fibrosis patients
Tóm tắt
Từ khóa
Tài liệu tham khảo
Yankaskas, 2004, Cystic fibrisos adult care. Consensus conference report, Chest, 125, 1S, 10.1378/chest.125.1_suppl.1S
Burroughs, 2000, Immunisation of pediatric solid organ transplant candidates and recipients, Clin Infect Dis, 30, 857, 10.1086/313823
Webb, 2000, Immunisation against varicella in end stage and pre-end stage renal failure, Arch Dis Child, 88, 141, 10.1136/adc.82.2.141
Giacchino, 2001, Hepatitis A vaccine in pediatric patients affected by metabolic liver diseases, Pediatr Infect Dis J, 20, 805, 10.1097/00006454-200108000-00018
van der Meer, 1996, Insufficient vaccination status of children with a chronic disease, Ned Tijdschr Geneeskd, 140, 1402
Williams, 1988, Immunisation policies and vaccine coverage among adults. The risk for missed opportunities, Ann Intern Med, 108, 616, 10.7326/0003-4819-108-4-616
De Serres, 2000, Morbidity of pertussis in adolescents and adults, J Infect Dis, 182, 174, 10.1086/315648
Birkebaek, 1999, Bordetella pertussis and chronic cough in adults, Clin Infect Dis, 29, 1239, 10.1086/313448
De Schutter, 2003, Molecular typing of Bordetella pertussis isolated recovered from Belgian children and their household members, Clin Infect Dis, 36, 1391, 10.1086/375071
Helwig, 1998, Childhood immunisation in the European Union, Eur J Pediatr, 157, 676, 10.1007/s004310050910
Schmitt, 2003, Child vaccination policies in Europe: a report from the Summits of Independent European Vaccination Experts, Lancet Infect Dis, 3, 103, 10.1016/S1473-3099(03)00519-X
Kasper, 1990, Fatal varicella after a single course of corticosteroids, Pediatr Infect Dis J, 9, 729, 10.1097/00006454-199010000-00009
Lang, 2004, Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection, Pediatr Infect Dis J, 23, 504, 10.1097/01.inf.0000129688.50588.ac
Hadler, 1991, Global impact of hepatitis A virus infection: changing patterns, 14
Akriviadis, 1989, Fulminant hepatitis A in intravenous drug users with a chronic liver disease, Ann Intern Med, 110, 838, 10.7326/0003-4819-110-10-838
Williams, 1996, Association between chronic liver disease and death from hepatitis A, United States, 1989–92 (abstract), A39
Lee, 1997, Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease, J Med Virol, 52, 215, 10.1002/(SICI)1096-9071(199706)52:2<215::AID-JMV16>3.0.CO;2-J
Keeffe, 1998, Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease, Hepatology, 27, 881, 10.1002/hep.510270336
Michielsen, 2000, Hepatitis vaccination in patients with chronic liver disease, Acta Gastro-Enterol. Belg., 63, 1
Bell, 2000, Hepatitis A and hepatitis B vaccination of patients with chronic liver disease, Acta Gastro-Enterol. Belg., 63, 359
Van Damme, 2001, Hepatitis B: vaccination programmes in Europe—an update, Vaccine, 19, 2375, 10.1016/S0264-410X(00)00457-6
Van Damme, 2002, Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001, J Med Virol, 67, 262, 10.1002/jmv.10091
Ling, 1999, The evolution of liver disease in cystic fibrosis, Arch Dis Child, 81, 129, 10.1136/adc.81.2.129
Wilschanski, 1999, Clinical and genetic risk factors for cystic fibrosis-related liver disease, Pediatrics, 103, 53, 10.1542/peds.103.1.52
Potter, 1997, Can the histologic changes of cystic fibrosis-associated hepatobiliary disease be predicted by clinical criteria?, J Pediatr Gastroenterol Nutr, 25, 32, 10.1097/00005176-199707000-00005
Neglia, 1995, The risk of cancer among patients with cystic fibrosis, N Engl J Med, 332, 494, 10.1056/NEJM199502233320803
Van Damme, 2001, Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults, J Med Virol, 65, 6, 10.1002/jmv.1094
Van Der Wielen, 2000, A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years, Pediatr Infect Dis J, 19, 848, 10.1097/00006454-200009000-00008
Centers for Disease Control and Prevention, 1996, Prevention of hepatitis A through active or passive immunisation: recommendations of the Advisory Committee on Immunization Practice (ACIP), MMWR, 445, 1
Craig, 2004, Prevention of hepatitis A with the hepatitis A vaccine, N Engl J Med, 350, 476, 10.1056/NEJMcp031540
Glismann, 2001, The EUVAC-NET survey: national measles surveillance systems in EU, Switzerland, Norway and Iceland, Eurosurveillance, 6, 105, 10.2807/esm.06.06.00206-en
Vitek, 1999, Increased protections during a measles outbreak of children previously vaccinated with a second dose of measles-mumps-rubella, Pediatr Infect Dis J, 18, 620, 10.1097/00006454-199907000-00010
American Academy of Pediatrics Committee on Infectious Diseases, 1997, Immunization of adolescents: recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association, Pediatrics, 99, 479, 10.1542/peds.99.3.479
American Academy of Pediatrics, 1998, Age for routine second administration of the second dose of measles-mumps-rubella vaccine, Pediatrics, 101, 129, 10.1542/peds.101.1.129
Choo, 1995, The epidemiology of varicella and its complications, J Infect Dis, 172, 706, 10.1093/infdis/172.3.706
Brisson, 2001, Epidemiology of varicella zoster infection in Canada and the United Kingdom, Epidemiol Infect, 127, 305, 10.1017/S0950268801005921
Galil, 2002, Outbreak of varicella at a day-care center despite vaccination, N Engl J Med, 347, 1909, 10.1056/NEJMoa021662
Bramley, 2003, vol. 11, 2
MacDonald, 1987, Varicella in children with cystic fibrosis, Pediatr Infect Dis J, 6, 414, 10.1097/00006454-198704000-00014
Ong, 1991, Varicella-zoster infection in adults with cystic fibrosis: role of acyclovir, Scand J Infect Dis, 23, 283, 10.3109/00365549109024311
Gogos, 1992, Varicella pneumonia in adults. A review of pulmonary manifestations, risk factors and treatment, Respiration, 59, 339, 10.1159/000196084
Pugh, 1998, Varicella infection and pneumonia among adults, Int J Infect Dis, 2, 205, 10.1016/S1201-9712(98)90054-6
Mer, 1998, Corticosteroids in life-threatening varicella pneumonia, Chest, 114, 426, 10.1378/chest.114.2.426
Koc, 2000, Varicella-zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors and clinical outcome, Biol Blood Marrow Transplant, 6, 44, 10.1016/S1083-8791(00)70051-6
Pandya, 2001, Varicella-zoster infection in pediatric solid-organ transplant recipients: a hospital-based study in the prevaricella vaccine era, Pediatr Transplant, 5, 153, 10.1034/j.1399-3046.2001.00048.x
2001, Simultaneous administration of varicella vaccine and other recommended childhood vaccines–United States, 1995–1999, MMWR Morb Mortal Wkly Rep, 50, 1058
Levin, 2003, Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-hose VZV vaccine, J Infect Dis, 188, 1336, 10.1086/379048
Thiry, 2002, The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium), Eur J Pediatr, 161, 588, 10.1007/s00431-002-1053-2
Vessey, 2001, Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy, J Pediatr, 139, 297, 10.1067/mpd.2001.116051
Gershon, 2002, Varicella vaccine—are two doses better than one?, N Engl J Med, 347, 1962, 10.1056/NEJMe020138
Hiatt, 1999, Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis, Pediatrics, 103, 619, 10.1542/peds.103.3.619
Peterson, 1981, Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma—possible synergism with Pseudomonas aeruginosa, Acta Paediatr Scand, 70, 623, 10.1111/j.1651-2227.1981.tb05757.x
Pribble, 1990, Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections, J Paediatr, 117, 200, 10.1016/S0022-3476(05)80530-X
Ferson, 1991, Impact of influenza on morbidity in children with cystic fibrosis, J Paediatr Child Health, 27, 308, 10.1111/j.1440-1754.1991.tb02545.x
Ramsey, 1989, The effect of respiratory viral infections on patients with cystic fibrosis, Am J Dis Child, 143, 662
Izurieta, 2000, Influenza and the rates of hospitalization for respiratory disease among infants and young children, N Engl J Med, 342, 232, 10.1056/NEJM200001273420402
Neuzil, 2000, The effect of influenza on hospitalizations, outpatient visits and courses of antibiotics in children, N Engl J Med, 342, 225, 10.1056/NEJM200001273420401
Glezen, 2000, Influenza and hospitalizations in children, N Engl J Med, 342, 1752, 10.1056/NEJM200006083422313
CDC, 2002, Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR, 51, 1
Wareing, 2002, Influenza update: vaccine development and clinical trials, Curr Opin Pulm Med, 8, 209, 10.1097/00063198-200205000-00010
Ong, 1991, Influenza vaccination in adults with cystic fibrosis, BMJ, 303, 557, 10.1136/bmj.303.6802.557
Gruber, 1994, Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study, J Infect Dis, 169, 241, 10.1093/infdis/169.2.241
Conway, 1992, Acute severe deterioration in cystic fibrosis associated with influenza A virus infection, Thorax, 47, 112, 10.1136/thx.47.2.112
Schaad, 2000, Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit vaccine in paediatric patients with cystic fibrosis, Antimicrob Agents Chemother, 44, 1163, 10.1128/AAC.44.5.1163-1167.2000
Stephenson, 2001, Influenza: vaccination and treatment, Eur Respir J, 17, 1282, 10.1183/09031936.01.00084301
Örtqvist, 2001, Pneumococcal vaccination: current and future issues, Eur Respir J, 18, 184, 10.1183/09031936.01.00084401
Lahiri, 2001, Pre-immunization anti-pneumococcal antibody levels are protective in a majority of patients with cystic fibrosis, Pediatrics, 108, e62, 10.1542/peds.108.4.e62
Amber, 1990, Increased risk of pneumococcal infections in cardiac transplant recipients, Transplantation, 122, 10.1097/00007890-199001000-00027
Linneman, 1979, Risk of pneumococcal infection in renal transplant patients, JAMA, 241, 2619, 10.1001/jama.1979.03290500027016
American Academy of Pediatrics, 2000, Pneumococcal infections, vol. 452, 458
Linneman, 1986, Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine, Arch Intern Med, 146, 1554, 10.1001/archinte.1986.00360200116019
Musher, 1990, Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type specific cell wall polysaccharide, J Infect Dis, 161, 728, 10.1093/infdis/161.4.728
Musher, 1993, Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination, Clin Infect Dis, 17, 66, 10.1093/clinids/17.1.66
Rubins, 1998, Magnitude, duration, quality and function of pneumococcal vaccine responses in elderly adults, J Infect Dis, 178, 431, 10.1086/515644
Shapiro, 1991, The protective efficacy of polyvalent pneumococcal polysaccharide vaccine, N Engl J Med, 325, 1453, 10.1056/NEJM199111213252101
Butler, 1993, Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations, JAMA, 270, 1826, 10.1001/jama.1993.03510150060030
Fine, 1994, Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials, Arch Intern Med, 154, 2666, 10.1001/archinte.1994.00420230051007
Sorensen, 1998, Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine, Pediatr Infect Dis, 17, 685, 10.1097/00006454-199808000-00005
Shinefield, 2000, Efficacy of pneumococcal conjugate vaccines in large scale field trials, Pediatr Infect Dis J, 19, 394, 10.1097/00006454-200004000-00036
Malfroot, 2001, Indication of pneumococcal vaccination in CF patients, Eur Respir J, 118, 539s
Stovall, 2001, Invasive pneumococcal infection in pediatric cardiac transplant patients, Pediatr Infect Dis J, 20, 946, 10.1097/00006454-200110000-00007
Von Kries, 2000, Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines, Clin Infect Dis, 31, 482, 10.1086/313984
Eskola, 1990, A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease, N Engl J Med, 323, 1381, 10.1056/NEJM199011153232004
De Schutter, 1999, Haemophilus influenzae in the lower respiratory tract of infants and children, Eur Respir J, 14, 155s
Breukels, 2002, Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed, Clin Infect Dis, 34, 191, 10.1086/338259
McVernon, 2003, Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis, Lancet, 361, 1521, 10.1016/S0140-6736(03)13171-6
Miller, 2001, Planning, registration, and implementation of an immunisation campaign against menigococcal serogroup C disease in the UK: a success story, Vaccine, 20, S58, 10.1016/S0264-410X(01)00299-7
Hall, 2001, Respiratory syncytial virus and parainfluenza virus, N Engl J Med, 344, 1917, 10.1056/NEJM200106213442507
Dudas, 1998, Respiratory syncytial virus vaccines, Clin Microbiol Rev, 11, 430, 10.1128/CMR.11.3.430
Piedra, 2000, Respiratory syncytial virus vaccines: recent developments, Pediatr Infect Dis J, 19, 805, 10.1097/00006454-200008000-00035
Stein, 1999, RSV in early life and risk of wheeze and allergy by age 13, Lancet, 354, 541, 10.1016/S0140-6736(98)10321-5
Lenney, 2001, RSV disease—is there a role for prevention?, Respir Med, 95, 170, 10.1053/rmed.2000.1018
Walsh, 1999, Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease, Am J Respir Crit Care Med, 160, 791, 10.1164/ajrccm.160.3.9901004
Hiatt, 1992, Respiratory viral infection and pulmonary function in infants with cystic fibrosis, Am Rev Respir Dis, 145, A115
Smyth, 1995, Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis, Arch Dis Child, 73, 117, 10.1136/adc.73.2.117
Johansen, 1992, Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis, Thorax, 47, 109, 10.1136/thx.47.2.109
Wang, 1984, Association of respiratory viral infection with pulmonary deterioration in patients with cystic fibrosis, N Engl J Med, 311, 1653, 10.1056/NEJM198412273112602
Armstrong, 1998, Severe viral respiratory infections in infants with cystic fibrosis, Pediatr Pulmonol, 26, 371, 10.1002/(SICI)1099-0496(199812)26:6<371::AID-PPUL1>3.0.CO;2-N
Abman, 1988, Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis, J Pediatr, 113, 826, 10.1016/S0022-3476(88)80008-8
Heinzl, 2002, Effects of inhaled gentamycin prophylaxis on acquisition of Pseudomonas aeruginosa in children with cystic fibrosis: a pilot study, Pediatr Pulmonol, 33, 32, 10.1002/ppul.10019
Groothuis, 1993, Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children, N Engl J Med, 329, 1524, 10.1056/NEJM199311183292102
Sorrentino, 2000, Effectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season, Pediatr Infect Dis J, 19, 1068, 10.1097/00006454-200011000-00007
Kim, 1969, Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine, Am J Epidemiol, 89, 422, 10.1093/oxfordjournals.aje.a120955
Karron, 1997, Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children, J Infect Dis, 176, 1428, 10.1086/514138
Englund, 1998, Maternal immunization against viral disease, Vaccine, 16, 1456, 10.1016/S0264-410X(98)00108-X
Lyczak, 2002, Lung infections associated with cystic fibrosis, Clin Microbiol Rev, 15, 194, 10.1128/CMR.15.2.194-222.2002
Tummler, 1997, Infections with Pseudomonas aeruginosa in patients with cystic fibrosis, Behring-Inst-Mitt, 98, 249
Holder, 2001, Pseudomonas vaccination and immunotherapy: an overview, J Burn Care Rehabil, 5, 311, 10.1097/00004630-200109000-00004
Keogan, 2000, Vaccines for preventing infection with Pseudomonas aeruginosa in people with cystic fibrosis, Cochrane Database Syst Rev, 2